Tilray Stock
Tilray provides pharmaceutical-grade cannabis products to patients, researchers, pharmacies, and governments.
About Tilray Stock
Tilray provides pharmaceutical-grade cannabis products to patients, researchers, pharmacies and governments. Tilray cultivates and delivers the benefits of medical cannabis safely and reliably. Healthcare practitioners and patients expect and deserve only the best service and products. Accordingly, Tilray provides expedited delivery, prompt follow-up, and consistent quality of each strain they harvest.
Funding History
| February 2018 | $60.0M |
|---|
Management
Director
Catherine Jacobson
Founder
Brendan Kennedy
Co-Founder
Christian Groh
Press
Seeking Alpha - Jun, 27 2018
International Financing Review - Jun, 25 2018
PitchBook News & Analysis - Jun, 22 2018
Axios - Jun, 21 2018
Business Wire (press release) - Apr, 4 2018
Business Wire (press release) - Mar, 19 2018
Other Companies
EquityZen does not have an affiliation with, formal relationship with, or endorsement from Tilray or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
